Blue Lake Biotechnology to Be Featured at the Biotechnology Innovation Organization (BIO) International Convention
ATHENS, Ga. and LOS GATOS, Calif., May 31, 2023 /PRNewswire/ — Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to protect against serious infectious diseases, announced today that company CEO Biao He, Ph.D., will present and host one-on-one partnering meetings at the 2023 Biotechnology Innovation Organization International … Read more